Medical Care Situation of People with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in Germany

• Published in: Medicina (Kaunas, Lithuania) Lithuania), 2021-06, Vol.57 (7), p.646
• Main Authors: Froehlich, Laura, Hattesohl, Daniel B R, Jason, Leonard A, Scheibenbogen, Carmen, Behrends, Uta, Thoma, Manuel
• Format: Article
• Language: English
• Subjects: Biomarkers; Canada; Chronic Fatigue Syndrome; Chronic illnesses; DePaul Symptom Questionnaire; Encephalomyelitis; Fatigue Syndrome, Chronic - diagnosis; Fatigue Syndrome, Chronic - epidemiology; Fatigue Syndrome, Chronic - therapy; Germany - epidemiology; Humans; medical care; Multiple sclerosis; Myalgic Encephalomyelitis; Patients; Questionnaires; Reproducibility of Results; Surveys and Questionnaires; Teenagers; Translations
• ISSN: 1648-9144; 1010-660X; 1648-9144
• DOI: 10.3390/medicina57070646

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a severe illness with the hallmark symptom of Post-Exertional Malaise (PEM). Currently, no biomarkers or established diagnostic tests for ME/CFS exist. In Germany, it is estimated that over 300,000 people are affected by ME/CFS. Research from the United States and the UK shows that patients with ME/CFS are medically underserved, as they face barriers to medical care access and are dissatisfied with medical care. The first aim of the current research was to investigate whether patients with ME/CFS are medically underserved in Germany in terms of access to and satisfaction with medical care. Second, we aimed at providing a German-language version of the DePaul Symptom Questionnaire Short Form (DSQ-SF) as a tool for ME/CFS diagnostics and research in German-speaking countries. The current research conducted an online questionnaire study in Germany investigating the medical care situation of patients with ME/CFS. The questionnaire was completed by 499 participants who fulfilled the Canadian Consensus Criteria and reported PEM of 14 h or longer. Participants frequently reported geographic and financial reasons for not using the available medical services. Furthermore, they reported low satisfaction with medical care by the physician they most frequently visited due to ME/CFS. The German version of the DSQ-SF showed good reliability, a one-factorial structure and construct validity, demonstrated by correlations with the SF-36 as a measure of functional status. Findings provide evidence that patients with ME/CFS in Germany are medically underserved. The German-language translation of the DSQ-SF provides a brief, reliable and valid instrument to assess ME/CFS symptoms to be used for research and clinical practice in German-speaking countries. Pathways to improve the medical care of patients with ME/CFS are discussed.